RotaShield Return? Biovirx Plans Global Reintroduction Of Vaccine
This article was originally published in The Pink Sheet Daily
Executive Summary
Biovirx obtained a global license from NIH; the firm will seek a partner for the U.S. and Europe. Wyeth withdrew the rotavirus vaccine in July 1999 due to an increased risk of intussusception in vaccinated infants.